Global Gastrointestinal Endoscopy Devices Market Size Likely to Grow at a CAGR of 5.4% By 2035

The market size of the global gastrointestinal endoscopy devices will be estimated at USD 11.6 billion in 2025 and is expected to grow between USD 12.2 billion in 2026 and about USD 19.6 billion by 2035 with a current CAGR of 5.4% during the period of 2026 to 2035.

Gastrointestinal Endoscopy Devices Market Revenue and Trends

Gastrointestinal endoscopy devices are a category of medical instruments that are exceptional and their main purpose is to visualize, diagnose, and treat the disorders of the gastrointestinal tract that comprises the esophagus, stomach, small intestine, and large intestine. These machines are the endoscope which can be either flexible or rigid and also contain the accompanying light sources, high-resolution cameras, and working passageways where the diagnostic and therapeutic tools such as biopsy forceps, snares, and stents are able to go through. With the help of these devices, the surgeons can perform and the patients can go through the diagnosing and treating of issues such as inflammation, ulcers, bleeding, polyps, and early-stage cancers in a minimally invasive way. Among the therapeutic procedures, the most common ones are polyp removal, hemostasis, dilation, and tissue resection. The high-definition and rapid imaging, along with less patient trauma, shorter recovery times and improved clinical outcomes, render these devices an essential part of modern gastrointestinal diagnosis and treatment.

What are the Factors That Have a Significant Contribution to the Growth of the Gastrointestinal Endoscopy Devices Market?

The gastrointestinal endoscopy devices market is experiencing very fast growth in the Asia Pacific region primarily due to the increasing number of patients with gastrointestinal diseases, the rising number of elderly people, and the growing awareness among people regarding the importance of early detection of diseases. China, India, Japan, and South Korea are countries where the number of colorectal and gastric cancer patients is increasing, together with the GI disorders caused by lifestyle changes, and this is a key factor in the demand for diagnostic and therapeutic endoscopic procedures.

The market is further assisted by better healthcare facilities, more government money spent on hospitals and screening programs, and ever-growing private healthcare providers. Moreover, the combination of low-priced and up-to-date endoscopy systems along with factors like the rise in medical tourism and the growing number of trained health professionals is speeding up the adoption of gastrointestinal endoscopy devices in the Asia Pacific region.

Additionally, AI's incorporation in detection and decision-making support is one of the key players in transforming the market of endoscopic devices for the gastrointestinal tract. Specifically, the computer-aided detection (CADe) and computer-aided diagnosis (CADx) algorithms are the ones that perform the endoscopic imaging task of evaluating and marking the areas of polyps, cancers at the very early stage, spots of bleeding, and even the minute transformations of the mucosa that might be overlooked in the routine check-up.

The inter-operator variation is significantly reduced by AI support, which in turn leads to higher adenoma detection rates and gives doctors the power to make faster and more confident decisions during surgeries. The integration of this technology into the workflow, the training and supervision of the less-experienced endoscopists, and the enhancement of quality assurance are significant factors in the large-scale adoption of AI-driven endoscopic systems in hospitals and clinics.

Segment Insight

By Type

The flexible gastrointestinal endoscopes segment is expected to grow at a significant rate over the forecast period. The factors behind the growth are its extensive clinical use, technical advancements, and enlargement of the application in procedures. The main driver of revenue increase is the increasing number of diagnostic and therapeutic GI procedures, among which are colonoscopy and upper GI endoscopy, as flexible endoscopes provide better maneuverability, patient comfort, and access to difficult GI anatomy. Technological improvements, such as high-definition imaging, image-enhanced visualization, and AI-assisted detection, are making the replacement cycles faster and are inviting healthcare providers to buy premium flexible endoscopy systems.

Regional Insights

North America held the highest market share in 2025. The growing technological advancements in the area and presence of the major players in the area. Also, the introduction of innovative solutions in the area flourishes the market growth.

Besides, the Asia Pacific market has the highest rate of growth in the gastrointestinal endoscopy devices market. The increasing expenditure on healthcare infrastructure and growing cases of cancer.

Report Scope

Recent Developments

In December 2024, PENTAX Medical, which is part of the HOYA Group, has received the US FDA 510(k) clearance for new models of the PENTAX Medical i20c Video Endoscope Series, including PENTAX Medical Video Colonoscope EC34-i20cL, PENTAX Medical Video Upper GI Scope EG27‑i20c, and Right/Left Wheel Extender OE-B17. (Source: https://www.prnewswire.com/news-releases/pentax-medical-obtained-us-fda-510k-clearance-for-new-models-of-the-pentax-medical-i20c-video-endoscope-series-302326311.html)

List of the prominent players in the Gastrointestinal Endoscopy Devices Market:

• HOYA Corporation (PENTAX Medical)

• Boston Scientific Corporation

• Fujifilm Holdings Corporation

• Johnson & Johnson Services Inc. (Ethicon Inc.)

• KARL STORZ SE & Co. KG

• Medtronic

• Stryker

• Olympus Corporation

• Smith+Nephew

• Cook

• CONMED Corporation

• Ambu A/S

• Richard Wolf GmbH

• STERIS plc

• Others

The Gastrointestinal Endoscopy Devices Market is segmented as follows:

By Type

• Rigid Gastrointestinal Endoscopes

• Flexible Gastrointestinal Endoscopes

• Disposable Gastrointestinal Endoscopes

By End Use

• Hospitals

• Outpatient Facilities

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America